$1 million for cancer research at Olivia Newton-John Cancer Research Institute

The Morrison Government is investing $1 million to expand a rare cancers clinical trial being conducted by the Olivia Newton-John Cancer Research Institute to reach patients living in regional areas.   The trial is focused on three rare cancers – gastrointestinal, neuroendocrine and genitourinary – and involves the immunotherapy drugs Ipilimumab and Nivolumab.   The…

Interview With Sabra Lane – ABC AM

E&OE…                       Topics: Domestic violence and mental health support services, $10 million to fund six new rare cancer and rare disease clinical trials, increasing the number of women in Parliament   SABRA LANE: The federal government set aside $10 million to fund six new clinical trials to test new treatments for rare diseases and injury.…

Interview With Jayne Azzopardi – Weekend Today

E&OE…                       Topics: More support for women with endometriosis; women in politics; electricity prices   JAYNE AZZOPARDI: Now to the Federal Government’s announcement this morning of more support for women living with endometriosis. The aim is to help the 10 per cent of Australian women who are diagnosed with the condition in the workplace.  …

More support for women with endometriosis this Women’s Health Week

The Morrison Government will provide more support for women with endometriosis by helping educate employers, doctors and nurses on managing this common but little known condition that affects over 700,000 Australian women.   Safe Work Australia will develop workplace-specific materials to educate employers on the prevalence and impact of endometriosis, so that they are better-equipped…

Doorstop – Melbourne

E&OE…                       Topics: $12 million to combat prostate cancer; Julie Bishop; gender representation in the Liberal Party.   GREG HUNT: I’m really delighted to be here today at Movember headquarters with Paul Villanti and the extraordinary team. People such as Alan and Rob and Joe, who are all prostate cancer survivors and thrivers.   This…